Brain antibodies in MS-patients — an activity parameter for immunosuppressive therapy?

por Henneberg, A.E., Pfau, J., Hartmann, P., Bittmann, H., Link, D., Wollinsky, K.H.
Publicado 1994

Quantifying ultra-rare pre-leukemic clones via targeted error-corrected sequencing

por Young, A L, Wong, T N, Hughes, A E O, Heath, S E, Ley, T J, Link, D C, Druley, T E
Publicado 2015